After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
STOK belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Stoke Therapeutics Inc is $1.01B. A total of 1.17 million shares were traded on the day, compared to an average of 701.82K shares.
In the most recent transaction, Allan Jonathan sold 13,712 shares of STOK for 15.00 per share on Aug 13 ’25. After the transaction, the GENERAL COUNSEL & CORP SEC now owns 19,631 company shares. In a previous transaction on Aug 13 ’25, JONATHAN ALLAN bought 13,712 shares at 13.53 per share.
Among the insiders who sold shares, Ticho Barry disposed of 4,504 shares on Aug 01 ’25 at a per-share price of $12.82. This resulted in the CHIEF MEDICAL OFFICER holding 16,775 shares of STOK after the transaction. In another insider transaction, Ticho Barry sold 4,503 shares at $11.63 per share on Jul 01 ’25. Company shares held by the CHIEF MEDICAL OFFICER now total 21,279.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, STOK has a high of $18.45 and a low of $5.35.
As of this writing, STOK has an earnings estimate of -$0.59 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.39 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.47 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. STOK’s latest balance sheet shows that the firm has $219.81M in Cash & Short Term Investments as of fiscal 2021. There were $1.51M in debt and $17.14M in liabilities at the time. Its Book Value Per Share was $6.12, while its Total Shareholder’s Equity was $217.78M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STOK is Buy with a score of 4.58.
